[Nature]
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial
文献作者：Kimberly J. Perez; Andressa Dias Costa; Alexander Jordan; Thomas B. Karasic; Dalia Elganainy; Suryun Kim; Chen Yuan; Dan Y. Gui; Runzi Tan; Sung Chul Hong; Xi Wang; Simona Cristea; Emma Coleman; Morgan Truitt; Tae Gyu Oh; Hui Zheng; C. Sloane Furniss; Lauren Brais; Alexandra Bird; Josh Remland; Vasilena Gocheva; Jennifer S. Thalappillil; Mark Anderson; James M. Cleary; Andrea Enzinger; Marios Giannakis; Kimmie Ng; Douglas A. Rubinson; Benjamin Schlechter; Rishi Surana; Harshabad Singh; Thomas Abrams; Ursina Teitelbaum; Natallia Izgur; Eliezer Allen; Peter S. Winter; Srivatsan Raghavan; Jen Jen Yeh; Daniel Von Hoff; Christopher Liddle; Michael Downes; Ronald M. Evans; Peter O’Dwyer; Andrew Aguirre; Jonathan A. Nowak; Brian M. Wolpin
10